Evidence map›Paper›PMID 37091988›Full record

ArticleiScience2023

SARS-CoV-2 awakens ancient retroviral genes and the expression of proinflammatory HERV-W envelope protein in COVID-19 patients.

Benjamin Charvet, Joanna Brunel, Justine Pierquin, Mathieu Iampietro, Didier Decimo, Nelly Queruel, Alexandre Lucas, María Del Mar Encabo-Berzosa, Izaskun Arenaz, Tania Perez Marmolejo and 11 more

Open access · goldAbstract read
In one paragraph

Article in iScience, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
7.8field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 40 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Review
  8. Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Review
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors at 7 institutions in 4 countries.

Benjamin CharvetGeNeuro Innovation, Lyon, France.
Joanna BrunelGeNeuro Innovation, Lyon, France.
Justine PierquinGeNeuro Innovation, Lyon, France.
Mathieu IampietroCIRI, International Center for Infectiology Research, INSERM U1111, CNRS UMR5308, Université de Lyon, Université Claude Bernard Lyon 1, Ecole Normale Supérieure de Lyon, Lyon, France.
Didier DecimoCIRI, International Center for Infectiology Research, INSERM U1111, CNRS UMR5308, Université de Lyon, Université Claude Bernard Lyon 1, Ecole Normale Supérieure de Lyon, Lyon, France.
Nelly QueruelGeNeuro Innovation, Lyon, France.
Alexandre LucasWe-Met platform, I2MC/Inserm/Université Paul Sabatier UMR1297, Toulouse, France.
María Del Mar Encabo-BerzosaBiobanco del Sistema de Salud de Aragón, Instituto Aragonés de Ciencias de la Salud (IACS), Zaragoza, Spain.
Izaskun ArenazBiobanco del Sistema de Salud de Aragón, Instituto Aragonés de Ciencias de la Salud (IACS), Zaragoza, Spain.
Tania Perez MarmolejoInstituto Nacional de Enfermedades Respiratorias Ismael Cosio Villegas, México Ciudad, México.
Arturo Ivan GonzalezInstituto Nacional de Enfermedades Respiratorias Ismael Cosio Villegas, México Ciudad, México.
Armando Castorena MaldonadoInstituto Nacional de Enfermedades Respiratorias Ismael Cosio Villegas, México Ciudad, México.
Cyrille MathieuCIRI, International Center for Infectiology Research, INSERM U1111, CNRS UMR5308, Université de Lyon, Université Claude Bernard Lyon 1, Ecole Normale Supérieure de Lyon, Lyon, France.
Patrick KüryDepartment of Neurology, Medical Faculty, Heinrich-Heine-University, Dusseldorf, Germany.
Jose Flores-RiveraDepartment of Neurology, National Institute of Neurology and Neurosurgery, Mexico City, Mexico.
Fernanda Torres-RuizCentro de investigación en Enfermedades Infecciosas, Instituto Nacional de Enfermedades Respiratorias Ismael Cosío Villegas, México Ciudad, México.
Santiago Avila-RiosCentro de investigación en Enfermedades Infecciosas, Instituto Nacional de Enfermedades Respiratorias Ismael Cosío Villegas, México Ciudad, México.
Gonzalo Salgado Montes de OcaCentro de investigación en Enfermedades Infecciosas, Instituto Nacional de Enfermedades Respiratorias Ismael Cosío Villegas, México Ciudad, México.
Jon SchoorlemmerARAID Fundación; Instituto Aragonés de Ciencias de la Salud (IACS); Grupo B46_20R de la DGA and GIIS-028 del IISA; all Zaragoza, Spain.
Hervé PerronGeNeuro Innovation, Lyon, France.
Branka HorvatCIRI, International Center for Infectiology Research, INSERM U1111, CNRS UMR5308, Université de Lyon, Université Claude Bernard Lyon 1, Ecole Normale Supérieure de Lyon, Lyon, France.
Instituto Nacional de Enfermedades Respiratorias · MXUniversité Claude Bernard Lyon 1 · FRInstituto Aragonés de Ciencias de la Salud · ESFundacion Agencia Aragonesa para la Investigacion y el Desarrollo · ESHeinrich Heine University Düsseldorf · DEInstituto Nacional de Neurología y Neurocirugía · MXUniversité Toulouse III - Paul Sabatier · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Patients with COVID-19 may develop abnormal inflammatory response, followed in some cases by severe disease and long-lasting syndromes. We show here that

Indexed as

Health sciencesMolecular GeneticsVirology

Identifiers

PMID37091988
PMCPMC10079620
OpenAlexW4362700135

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.